Zobrazeno 1 - 4
of 4
pro vyhledávání: '"María Luisa Villareal"'
Autor:
Anabel Ortiz Caltempa, Marisela Hernández, Ana Lilia Pérez, Liliana Aguilar, Cynthia Guzmán, Dolores Adriana Ayón-Núñez, Gladis Fragoso, Raúl J. Bobes, Maria Eugenia López, Edda Sciutto, María Luisa Villareal
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Parasitic diseases have a major impact on human and animal health worldwide. Despite the availability of effective anti-parasitic drugs, their excessive and uncontrolled use has promoted the emergence of drug resistance, severely affecting ecosystems
Externí odkaz:
https://doaj.org/article/d24dc2d6293f414a8dbe27bf5827d256
Autor:
María Luisa Villareal, Aurora Rodríguez-Álvarez, Jean-Michel Grévy, Rosario del Carmen Flores Vallejo, Carla Gabriela Martínez-De-León
Publikováno v:
New Journal of Chemistry. 44:20676-20687
Five new structurally related half-sandwich cationic Ru(II) complexes of general formula [(η6-p-cymene)RuL]Cl (6) and [(η6-p-cymene)RuL]PF6 (L = [2-C8H5N(Ph2PNC6H4XR)]− [R = C6H5, X = S (9), and Se (6, and 10); R = CH3, X = S (11), and Se (12)])
Autor:
Jacquelynne Cervantes, Edda Sciutto, Marisela Hernández, Gladis Fragoso, María Luisa Villareal, Nelly Villalobos, Anabel Ortiz Caltempa, Cynthia Guzmán
Parasitic diseases fecally transmitted, such taeniasis/cysticercosis Taenia solium binomial, represent a health problem whose incidence continues due to the prevalence of inadequate sanitary conditions, particularly in developing countries. When the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4991e55e59b1399c3eb5b7c63d3caf0d
http://www.intechopen.com/articles/show/title/development-of-an-oral-vaccine-for-the-control-of-cysticercosis
http://www.intechopen.com/articles/show/title/development-of-an-oral-vaccine-for-the-control-of-cysticercosis
Autor:
María Luisa Villareal, Patricia García y García, Raymundo Cea-Olivares, Marcela López-Cardoso
Publikováno v:
Metal-Based Drugs
O-Cholesteryl-O-phenyl-N-phenylphosphoramidate (1) and four organotin (lV) derivatives of the ambidentate O-cholesteryl-O -phenyl phosphorothioate ligand formulated as Me3 SnOSPR’R”(2), Ph3 SnOSPR’R”(3), O(CH2CH2S)2 Sn(n-Bu)OSPR’R”(4), S(